ORCID as entered in ROS

Select Publications
2020, 'Hospitalized fracture rates amongst patients with chronic kidney disease in Australia using data linkage', Nephrology, 25, pp. 475 - 482, http://dx.doi.org/10.1111/nep.13681
,2020, 'Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis', Journal of Cardiac Failure, 26, pp. 482 - 491, http://dx.doi.org/10.1016/j.cardfail.2020.03.010
,2020, 'SO017EFFECT OF HIGH-CUTOFF DIALYSIS FOR ACUTE KIDNEY INJURY SECONDARY TO CAST NEPHROPATHY IN PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS', Nephrology Dialysis Transplantation, 35, http://dx.doi.org/10.1093/ndt/gfaa139.so017
,2020, 'Impact of supplemental private health insurance on dialysis and outcomes', Internal Medicine Journal, 50, pp. 542 - 549, http://dx.doi.org/10.1111/imj.14375
,2020, 'Incidence and associations of chronic kidney disease in community participants with diabetes: A 5-year prospective analysis of the EXTEND45 study', Diabetes Care, 43, pp. 982 - 990, http://dx.doi.org/10.2337/dc19-1803
,2020, 'Examining outcomes in chronic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study', JMIR Research Protocols, 9, pp. e15646, http://dx.doi.org/10.2196/15646
,2020, 'Examining outcomes in chronic disease in the 45 and up study (the EXTEnD45 study): Protocol for an Australian linked cohort study', JMIR Research Protocols, 9, pp. e15646, http://dx.doi.org/10.2196/15646
,2020, 'Successful kidney transplantation in a patient with stable multiple myeloma', Internal Medicine Journal, 50, pp. 492 - 494, http://dx.doi.org/10.1111/imj.14790
,2020, 'Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography', Journal of the American College of Cardiology, 75, pp. 1311 - 1320, http://dx.doi.org/10.1016/j.jacc.2020.01.023
,2020, 'Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: A longitudinal study', BMJ Open Diabetes Research and Care, 8, pp. e000842, http://dx.doi.org/10.1136/bmjdrc-2019-000842
,2020, 'Reducing the Burden of Dialysis Catheter Complications: A National Approach (REDUCCTION)', Journal of the American Society of Nephrology, 31, pp. B2 - B2, http://dx.doi.org/10.1681/asn.20203110s1b2c
,2020, 'SAT-299 Change in Health-Related Quality of Life over 18 Months among Individuals on Maintenance Haemodialysis in India', Kidney International Reports, 5, pp. S126 - S126, http://dx.doi.org/10.1016/j.ekir.2020.02.318
,2020, 'Sex Differences in CKD Prevalence in Asia: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 31, pp. 179 - 179, http://dx.doi.org/10.1681/asn.20203110s1179c
,2020, 'SUN-128 A CO-DESIGNED INTEGRATED DIABETES AND KIDNEY DISEASE MODEL OF CARE IMPROVES DIABETES SELF-CARE AMONG PATIENTS WITH COMORBID DIABETES AND KIDNEY DISEASE', Kidney International Reports, 5, pp. S255 - S255, http://dx.doi.org/10.1016/j.ekir.2020.02.655
,2020, 'SUN-129 ACTIVATION LEVELS AMONG PATIENTS WITH COMORBID DIABETES AND KIDNEY DISEASE ATTENDING A CO-DESIGNED INTEGRATED MODEL OF CARE: A LONGITUDINAL STUDY', Kidney International Reports, 5, pp. S255 - S255, http://dx.doi.org/10.1016/j.ekir.2020.02.656
,2020, 'SUN-180 SOCIO-DEMOGRAPHIC CHARACTERISTICS AND OUTCOMES AT 18 MONTHS OF A COHORT OF ESKD PATIENTS STARTING HEMODIALYSIS IN INDIA', Kidney International Reports, 5, pp. S273 - S274, http://dx.doi.org/10.1016/j.ekir.2020.02.713
,2019, 'Varying association of extended hours dialysis with quality of life', Clinical Journal of the American Society of Nephrology, 14, pp. 1751 - 1762, http://dx.doi.org/10.2215/CJN.06800619
,2019, 'The Plasma-Lyte 148 versus Saline (PLUS) study protocol amendment', Critical Care and Resuscitation, 21, pp. 284 - 286
,2019, 'Arteriovenous access practices in Australian and New Zealand dialysis units', Journal of Vascular Access, 20, pp. 740 - 745, http://dx.doi.org/10.1177/1129729819851061
,2019, 'Statistical Analysis Plan for the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial', Critical Care and Resuscitation
,2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087
,2019, 'Dialysis catheter management practices in Australia and New Zealand', Nephrology, 24, pp. 827 - 834, http://dx.doi.org/10.1111/nep.13507
,2019, 'Inpatient notes: Preventing contrast-associated acute kidney injury—putting the issue to rest', Annals of Internal Medicine, 171, pp. HO2 - HO3, http://dx.doi.org/10.7326/M19-1846
,2019, 'The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study', Plos One, 14, pp. e0219685, http://dx.doi.org/10.1371/journal.pone.0219685
,2019, 'Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial', JAMA Network Open, 2, pp. e195418, http://dx.doi.org/10.1001/jamanetworkopen.2019.5418
,2019, 'STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury: Study Protocol for a Multi-National, Multi-Center, Randomized Controlled Trial.', Canadian Journal of Kidney Health and Disease, 6, http://dx.doi.org/10.1177/2054358119852937
,2019, 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial', Lancet, 393, pp. 1937 - 1947, http://dx.doi.org/10.1016/S0140-6736(19)30772-X
,2019, 'Effectiveness of corticosteroid compared with non-corticosteroid therapy for the treatment of drug-induced acute interstitial nephritis: a systematic review', Internal Medicine Journal, 49, pp. 562 - 569, http://dx.doi.org/10.1111/imj.14081
,2019, 'SOFA coagulation score and changes in platelet counts in severe acute kidney injury: Analysis from the randomized evaluation of normal versus augmented level (RENAL) study', Nephrology, 24, pp. 518 - 525, http://dx.doi.org/10.1111/nep.13387
,2019, 'Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials', BMC Cardiovascular Disorders, 19, pp. 87, http://dx.doi.org/10.1186/s12872-019-1054-y
,2019, 'Methodological challenges to collecting clinical and economic outcome data: Lessons from the pilot dialysis outcomes India study', Nephrology, 24, pp. 445 - 449, http://dx.doi.org/10.1111/nep.13257
,2019, 'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', Plos One, 14, pp. e0213192, http://dx.doi.org/10.1371/journal.pone.0213192
,2019, 'Sex and mortality in septic severe acute kidney injury', Journal of Critical Care, 49, pp. 70 - 76, http://dx.doi.org/10.1016/j.jcrc.2018.10.017
,2019, 'HMG-CoA reductase inhibitors (statins) and acute kidney injury: A secondary analysis of renal study outcomes', Nephrology, 24, pp. 912 - 918, http://dx.doi.org/10.1111/nep.13597
,2019, 'Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease', Journal of Diabetes and Its Complications, 33, pp. 63 - 68, http://dx.doi.org/10.1016/j.jdiacomp.2018.09.020
,2019, 'Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort', Canadian Journal of Kidney Health and Disease, 6, pp. 2054358119879896, http://dx.doi.org/10.1177/2054358119879896
,2019, 'Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol', BMJ Open, 9, pp. bmjopen-2018-023736, http://dx.doi.org/10.1136/bmjopen-2018-023736
,2019, 'SAT-029 Haemodialysis in Fiji', Kidney International Reports, 4, pp. S15 - S15, http://dx.doi.org/10.1016/j.ekir.2019.05.051
,2019, 'SAT-039 Socio-Demographic Characteristics, Out of Pocket Expenditure, Quality of Life and Six Months Treatment Outcomes of Haemodialysis Patients in India', Kidney International Reports, 4, pp. S20 - S20, http://dx.doi.org/10.1016/j.ekir.2019.05.062
,2019, 'SAT-047 REASONS FOR DIALYSIS CATHETER INSERTION – REAL TIME DATA FROM THE REDUCCTION PROJECT', Kidney International Reports, 4, pp. S23 - S23, http://dx.doi.org/10.1016/j.ekir.2019.05.070
,2019, 'SAT-229 DIALYSIS IN ZIMBABWE', Kidney International Reports, 4, pp. S102 - S102, http://dx.doi.org/10.1016/j.ekir.2019.05.264
,2019, 'SUN-057 Reducing Central Venous Catheter Burden in Haemodialysis Patients: The Impact of Changing Practice within an Australian Renal Unit', Kidney International Reports, 4, pp. S178 - S178, http://dx.doi.org/10.1016/j.ekir.2019.05.453
,2019, 'SUN-058 Variations in Environmentally Sustainable Practice within Australian Dialysis Units: Time for a Nationwide Approach?', Kidney International Reports, 4, pp. S178 - S178, http://dx.doi.org/10.1016/j.ekir.2019.05.454
,2019, 'SUN-178 The Impact of Acute Kidney Injury Requiring Haemodialysis on Patient Survival: 10 Years of Prospective Data', Kidney International Reports, 4, pp. S232 - S232, http://dx.doi.org/10.1016/j.ekir.2019.05.580
,2019, 'SUN-266 HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH COMORBID DIABETES AND KIDNEY DISEASE ATTENDING A CO-DESIGNED INTEGRATED MODEL OF CARE: A LONGITUDINAL STUDY', Kidney International Reports, 4, pp. S270 - S270, http://dx.doi.org/10.1016/j.ekir.2019.05.671
,2019, 'SUN-292 BENEFITS AND HARMS OF VITAMIN D COMPOUNDS IN ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', Kidney International Reports, 4, pp. S281 - S281, http://dx.doi.org/10.1016/j.ekir.2019.05.797
,2018, 'Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial', Jacc Cardiovascular Interventions, 11, pp. 2254 - 2261, http://dx.doi.org/10.1016/j.jcin.2018.07.044
,2018, 'Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease', Health and Quality of Life Outcomes, 16, pp. 215, http://dx.doi.org/10.1186/s12955-018-1044-2
,2018, 'Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India', Kidney International, 94, pp. 440 - 445, http://dx.doi.org/10.1016/j.kint.2018.03.028
,2018, 'Models of care for co-morbid diabetes and chronic kidney disease', Nephrology, 23, pp. 711 - 717, http://dx.doi.org/10.1111/nep.13232
,